Show source-provided references
5. Pharmacoeconomic management of patient with severe asthma in the Emergency Department: Retrospective multicentric and cost of illness study
6. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review
10.1001/jama.2020.12839 ↗8. Pathophysiology of COVID-19-associated acute respiratory distress syndrome: A multicentre prospective observational study
10.1016/S2213-2600(20)30370-2 ↗9. Non-COVID-19 admissions to the emergency department during the pandemic second wave in Italy: What is changed from the first wave?
10.1016/j.ajem.2020.11.046 ↗14. How to use the nominal group and Delphi techniques
16. Hanson, K.E., Altayar, O., Caliendo, A.M., Arias, C.A., Englund, J.A., Hayden, M.K., Lee, M.J., Loeb, M., Patel, R., and El Alayli, A. (2021). The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Antigen Testing. Clin. Infect. Dis.
10.1093/cid/ciab557 ↗17. Managing Asthma in Adolescents and Adults: 2020 Asthma Guideline Update From the National Asthma Education and Prevention Program
10.1001/jama.2020.21974 ↗18. Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases
10.1148/radiol.2020200642 ↗21. Thoracic imaging tests for the diagnosis of COVID-19
23. Assessment and management of adults with asthma during the covid-19 pandemic
10.1136/bmj.m2092 ↗32. The Type 2 Asthma Mediator IL-13 Inhibits Severe Acute Respiratory Syndrome Coronavirus 2 Infection of Bronchial Epithelium
10.1165/rcmb.2021-0364OC ↗35. Asthma and risk of infection, hospitalization, ICU admission and mortality from COVID-19: Systematic review and meta-analysis
10.1080/02770903.2021.1888116 ↗37. Does Asthma Increase the Mortality of Patients with COVID-19?: A Systematic Review and Meta-Analysis
10.1159/000510953 ↗40. Reply Letter—COVID-19 (Novel Coronavirus 2019)—Recent trends
41. Real-life impact of COVID-19 pandemic lockdown on the management of pediatric and adult asthma: A survey by the EAACI Asthma Section
10.1111/all.14831 ↗45. Ashour, H.M., Elkhatib, W.F., Rahman, M.M., and Elshabrawy, H.A. (2020). Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks. Pathogens, 9.
10.3390/pathogens9030186 ↗47. Lafaurie, M., Martin-Blondel, G., Delobel, P., Kamar, N., Charpentier, S., Sommet, A., and Moulis, G. (2021). Impact of previous exposure to systemic corticosteroids on unfavorable outcome in patients hospitalized for COVID-19. BMC Pharmacol. Toxicol., 22.
10.1186/s40360-021-00480-3 ↗49. Choi, J.C., Jung, S.Y., Yoon, U.A., You, S.H., Kim, M.S., Baek, M.S., Jung, J.W., and Kim, W.Y. (2020). Inhaled Corticosteroids and COVID-19 Risk and Mortality: A Nationwide Cohort Study. J. Clin. Med., 9.
10.3390/jcm9113406 ↗50. COVID-19 risk and outcomes in adult asthmatic patients treated with biologics or systemic corticosteroids: Nationwide real-world evidence
10.1016/j.jaci.2021.06.006 ↗51. Inhaled corticosteroids for the treatment of COVID-19
56. Motta, L.P., Silva, P., Borguezan, B.M., Amaral, J., Milagres, L.G., Bóia, M.N., Ferraz, M.R., Mogami, R., Nunes, R.A., and Melo, P.L. (2021). An emergency system for monitoring pulse oximetry, peak expiratory flow, and body temperature of patients with COVID-19 at home: Development and preliminary application. PLoS ONE, 16.
10.1371/journal.pone.0247635 ↗58. The outcomes and acceptance of pressurized metered-dose inhaler bronchodilators with venturi mask modified spacer in the outpatient emergency department during the COVID-19 pandemic
10.1111/jcpt.13410 ↗59. Risk of Transmitting Coronavirus Disease 2019 During Nebulizer Treatment: A Systematic Review
60. Tran, K., Cimon, K., Severn, M., Pessoa-Silva, C.L., and Conly, J. (2012). Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: A systematic review. PLoS ONE, 7.
10.1371/journal.pone.0035797 ↗62. Corticosteroids for preventing relapse following acute exacerbations of asthma
63. Early emergency department treatment of acute asthma with systemic corticosteroids
67. Antibiotics for exacerbations of asthma
71. COVID-19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments
10.1111/all.14532 ↗73. Brittle asthma
79. Asthma phenotypes, associated comorbidities, and long-term symptoms in COVID-19
10.1111/all.14972 ↗82. Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: A modelling study
10.1016/S2214-109X(20)30264-3 ↗84. Follow-up of patients with uncontrolled asthma: Clinical features of asthma patients according to the level of control achieved (the COAS study)
10.1183/13993003.01885-2015 ↗85. Bajowala, S., Shih, J., Varshney, P., and Elliott, T. (2022). The Future of Telehealth for Allergic Disease. J. Allergy Clin. Immunol. Pract.
10.1016/j.jaip.2022.08.022 ↗87. COVID-19 (Novel Coronavirus 2019)—Recent trends
92. Management of asthma during the Coronavirus disease 2019 outbreak
93. British Toracic Society (2022, July 18). Advice for Healthcare Professionals Treating People with Asthma (Adults) in Relation to COVID-19. Available online: https://www.brit-thoracic.org.uk/document-library/quality-improvement/covid-19/bts-advice-for-healthcare-professionals-treating-patients-with-asthma/.
94. GINA Scientific Committee (2022, July 18). Global Strategy for Asthma Management and Prevention Updated 2022. Available online: https://ginasthma.org/wp-content/uploads/2022/07/GINA-Main-Report-2022-FINAL-22-07-01-WMS.pdf.
95. National Asthma Council Australia (2022, July 18). Australian Asthma Handbook—Managing Asthma during the COVID-19 (SARS-CoV-2) Pandemic 2020. Available online: https://www.asthmahandbook.org.au/clinical-issues/covid-19.
96. Moher, D., Liberati, A., Tetzlaff, J., and Altman, D.G. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med., 6.
10.1371/journal.pmed.1000097 ↗